Acadia Healthcare’s (ACHC) Outperform Rating Reaffirmed at Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of Acadia Healthcare (NASDAQ:ACHC) in a report issued on Friday morning,Benzinga reports. They currently have a $64.00 price objective on the stock.

ACHC has been the topic of a number of other reports. TD Cowen reduced their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday. Barclays decreased their price objective on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research report on Friday, November 22nd. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their target price for the stock from $45.00 to $75.00 in a report on Thursday, December 12th. Cantor Fitzgerald restated a “neutral” rating and issued a $52.00 price target on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Finally, StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Trading Down 0.4 %

Shares of ACHC stock opened at $44.92 on Friday. The stock’s 50-day moving average price is $40.48 and its 200-day moving average price is $58.19. Acadia Healthcare has a 12-month low of $36.50 and a 12-month high of $87.77. The stock has a market capitalization of $4.17 billion, a price-to-earnings ratio of 14.73, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. During the same period in the prior year, the company earned $0.91 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year. Equities research analysts predict that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. State Street Corp raised its stake in shares of Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after acquiring an additional 95,613 shares in the last quarter. JPMorgan Chase & Co. raised its position in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after purchasing an additional 454,044 shares in the last quarter. LMR Partners LLP bought a new position in shares of Acadia Healthcare during the 3rd quarter worth $1,616,000. Principal Financial Group Inc. increased its stake in shares of Acadia Healthcare by 2.1% during the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock valued at $41,653,000 after buying an additional 13,368 shares during the period. Finally, Sivik Global Healthcare LLC raised its holdings in shares of Acadia Healthcare by 43.7% in the third quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock valued at $7,292,000 after acquiring an additional 34,997 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.